For bladder cancer, FUNDC1 was found to have a protective effect on overall survival (OS: HR = 0.59, 95% CI from 0.44 to 0.8, logrank P = 0.00045). This evidence concerns the gene FUNDC1 and urinary bladder carcinoma.